14:00 - 15:20
- 第一阶段:主题报告
- Session I: Keynote Speech
主持人 Moderator
- 高慧, 艾昆纬临床运营解决方案商务总监
- GAO Hui , Business Development Director, IQVIA
14:00 - 14:20
- 主题报告1
- Keynote Speech 1
- 中国创新医药企业出海国际化概览
- Landscape of Globalization by Chinese Biotechs
- 陈丽娟, 艾昆纬亚太区商务拓展高级副总裁
- Emily TAN, Senior Vice President Business development, R&DS APAC,IQVIA
14:20 - 14:40
- 主题报告2
- Keynote Speech 2
- 和黄医药的创新药国际化之路
- Path to Global Growth
- 崔昳昤, 和黄医药执行副总裁
- CUI Yiling, Executive Vice President, HUTCHMED
14:40 - 15:00
- 主题报告3
- Keynote Speech 3
- 中国创新,全球价值:制药国际化的持久战与系统工程
- China’s Innovation, Global Value: Sustained, Systematic Globalization
- 许晓建, 恒瑞医药股份有限公司集团副总裁
- Thomas XU, Corporate VP, Jiangsu Hengrui Pharmaceuticals
15:00 - 15:20
- 主题报告4
- Keynote Speech 4
- 立足中国,服务全球
- Rooted in China, Serving the World
- 徐景辉, 思拓凡中国首席技术官
- XU Jinghui, Chief Technology Officer, Cytiva China
15:20 - 17:00
- 第二阶段:主题讨论阶段
- Session II: Panel
15:20 - 16:10
- 主题讨论1
- Panel 1
- 中国医药企业全球化发展:战略布局与出海策略、监管协同
- Global Development of Chinese Pharmaceutical Enterprises: Strategic Planning, International Expansion, and Regulatory Harmonization
主持人 Moderator
- 杜新, 深圳埃格林医药首席执行官
- DU Xin, CEO of Evergreen Therapeutics
Panel嘉宾 Panelist
- 万江, 贝达药业资深副总裁兼首席运营官
- John WAN, Senior Vice President& Chief Operating Officer of Betta Pharma
- 崔昳昤, 和黄医药执行副总裁
- CUI Yiling, Executive Vice President, HUTCHMED
- 宇文镐, 斯丹姆医药全球注册高级副总裁兼首席商务官
- Howard Yuwen, SVP & CBO at SDM Bioservices
- 徐景辉, 思拓凡中国首席技术官
- XU Jinghui, Chief Technology Officer, Cytiva China
16:10 - 17:00
- 主题讨论2
- Panel 2
- 中国企业出海战略研讨
- Chinese Companies’ Global Expansion Strategies
主持人 Moderator
- 李伊吕, 瑞银医疗行业董事总经理
- Alfred LI, Managing Director, Asia Healthcare Team, UBS
Panel嘉宾 Panelist
- 张丹, 昆翎医药联合创始人兼首席战略官,谱新生物联合创始人兼联席董事长
- ZHANG Dan, Executive Chairman of ClinChoice
Co-founder and co-chairman of Jiangsu Hillgene Biopharma Co.,Ltd.
- 程慧, 海正药业执行董事、总经理
- CHENG Hui, Executive Director and General Manager of Hisun Inowave
- 孙程, 甘李药业股份有限公司副总裁、CFO
- SUN Cheng, Vice President & CFO, Gan & Lee Pharmaceuticals, Co., Ltd.
- 缪瑰丽, 四环医药首席财务官
- Julia MIAO, CFO, Sihuan Pharmaceutical Group Holdings Com. Ltd